Corporations
make a difference

Read more

Treatment

The ARSACS Foundation is now
working with pharmaceutical companies
to develop a treatment for ARSACS

Read more

Several research projects
are currently funded
by the Foundation
in Canada and abroad

Read more

The Ataxia gene can be
passed through many generations
without manifesting any symptoms

Read more

We need your support
to pursue research that heals

How can you help?

Donate
`

Latest News

Nov

20

2014

The Foundation is funding six new research projects

The Foundation of Ataxia Charlevoix-Saguenay is funding six new ARSACS research projects for 2014-2015.

Read More

Oct

28

2014

Third international symposium on ARSACS

The 3rd symposium on ARSACS will be held on November 12th and 13th,2014 in Montreal.Several experts in the field will participate at this conference. Symposium Program. You can register now.

Read More

Oct

17

2014

Preliminary work with Olivier Lambercy from Zurich paid off

Following a visit by Olivier Lambercy, a Swiss researcher to Saguenay back in September 2012 to present research from his laboratory, we are pleased that the preliminary work has paid off. We are beginning the process of analyzing the results of its tool for the entire cohort but already the pilot results are promising.

Oct

06

2014

ARSACS research team article published in the Oxford Journals

The ARSACS research team article, under the direction of Dr. Bernard Brais, has been published in the Oxford Journals of the prestigious Oxford University. The abstract of the article "Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay" can be found in the Human Molecular Genetics. Full version.

Oct

01

2014

Invitation to the Dîner des Producteurs

You are invited to the Dîner des Producteurs on Thursday December 4th 2014. Reserve your table now for this annual fundraing event by completing the attached form.

Sept

17

2014

Dr. Peter McPherson inducted into the Royal Society of Canada

Dr. Peter McPherson has been named a Fellow of the Royal Society of Canada (RSC). Dr. Pherson is one of the four Fellows from McGill University and is a member of the Ataxia Charlevoix-Saguenay Foundation research team. The induction ceremony will be in November in Quebec city. For more information, see McGill news release

Read More

June

28

2014

Research funding at any time

As part of its ARSACS research funding program, the Foundation of Ataxia Charlevoix-Saguenay has decided that it will consider all grant applications related to research on ARSACS. At any time, researchers interested in pursuing this funding opportunity may contact the Foundation by email at ataxia@arsacs.com.


Who We Are


What We Do

Funding
Funding
process
Team
Research
Research
process
Discovery
Trials
Trials

The Ataxia Charlevoix-Saguenay Foundation is a charitable organisation supported entirely by private donations. Different events are organised during the year by families, friends and community groups to raise funds to support research on ARSACS.


Since its creation, the Foundation has been successful in assembling a great team at all levels of the organisation (board, advisors, researchers, contributors and partners). The researchers are well respected in their field and have an international reputation for excellence.


The main research objective of the Ataxia Charlevoix-Saguenay Foundation is to develop a treatment for ARSACS. Several research projects on ARSACS are currently funded by the Foundation in Canada and abroad. Over 98% of the funds raised are allocated to research.


The main research objective of the Ataxia Charlevoix-Saguenay Foundation is to develop a treatment for ARSACS.


The first therapeutic tests on transgenic ARSACS mice conducted in the Spring 2013 were very positive. For a short study, the tests demonstrated some beneficial effect on the physical performance of the mice. Discussions are underway to determine the next step.